)
Annexon (ANNX) investor relations material
Annexon Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
The annual meeting is scheduled for June 11, 2026, to be held virtually, with voting on four key proposals and director elections.
Only stockholders of record as of April 13, 2026, are eligible to vote, with 162,507,278 shares outstanding.
The Board recommends voting in favor of all proposals, including director elections, auditor ratification, executive compensation, and an amendment to increase authorized shares.
Voting matters and shareholder proposals
Four proposals: election of two Class III directors, ratification of KPMG LLP as auditor, advisory approval of executive compensation, and amendment to increase authorized shares from 300M to 500M.
Board recommends voting “For” all proposals.
Shareholders may submit proposals for the 2027 meeting between February 11 and March 13, 2027.
Board of directors and corporate governance
Board consists of eight members, with a majority deemed independent under Nasdaq rules.
Chair and CEO roles are separated; current chair is Thomas G. Wiggans, who will retire at the 2026 meeting.
Four standing committees: Audit, Compensation, Nominating and Corporate Governance, and Science and Technology.
Board diversity emphasized, with 56% female employees and 24% from diverse backgrounds as of March 2026.
- Pivotal data and regulatory filings in GBS, GA, and ANX1502 expected to drive major milestones in 2026.ANNX
25th Annual Needham Virtual Healthcare Conference15 Apr 2026 - Late-stage pipeline advances and strong cash position support multiple 2026 milestones.ANNX
Q4 202530 Mar 2026 - Phase 3 trial for C1q inhibition in GA is fully enrolled, with pivotal results due Q4 2026.ANNX
KOL event20 Mar 2026 - Late-stage neuroinflammatory pipeline poised for major clinical and commercial milestones.ANNX
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - ANX005 30 mg/kg met key efficacy and safety endpoints in GBS, advancing toward FDA submission.ANNX
Study Update31 Jan 2026 - Phase III GBS and GA data show strong efficacy, with regulatory and commercial momentum building.ANNX
2024 Wells Fargo Healthcare Conference22 Jan 2026 - Phase III GBS data show rapid, durable efficacy, with key regulatory and pipeline milestones ahead.ANNX
2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026 - Pivotal 2026 catalysts for late-stage neuroinflammatory disease therapies with blockbuster potential.ANNX
44th Annual J.P. Morgan Healthcare Conference16 Jan 2026 - Positive GBS Phase III, oral therapy progress, and global GA trial highlight strong pipeline.ANNX
Jefferies London Healthcare Conference 202413 Jan 2026
Next Annexon earnings date
Next Annexon earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage